StockData
Vaccinex, Inc. logo

Vaccinex, Inc. (VCNX) stock

VCNXOTCPharmaceutical PreparationsFiscal year ends December 31
Financials through Q4 FY2024, quarter ended Dec 31, 2024Last filing: 10-K on Apr 15, 2025
$1.00−0.01 (-0.99%)

Close on Oct 19, 2026Market cap $3.22MP/E –Yield –

Earnings

Vaccinex's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.

Next report
–
Not yet scheduled
Revenue
–
EPS
–
Latest guidance
None
No outlook given in releases

Quarterly results

Revenue and earnings per share from each of Vaccinex's earnings releases, newest first

QuarterReportedRevenueYoYEPSSource
Q1 FY2021ended Mar 31, 2021May 17, 2021before the open–––Filing
Q4 FY2020ended Dec 31, 2020Mar 16, 2021before the open–––Filing

Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.

Guidance

Vaccinex has not given guidance in its releases

Many companies give their outlook only on the conference call or not at all. When Vaccinex puts a forecast in an earnings release, it is listed here with the exact sentence.

Press releases

Releases Vaccinex filed with the SEC as exhibits to Form 8-K or 6-K

  1. Update
  2. News
  3. Update
  4. News
  5. Update
  6. News
  7. News
  8. Update
  9. Update
  10. News
  11. Update
  12. Update
  13. Update
  14. News
  15. Update

See a number that looks wrong?